Control-IQ Technology

The t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology can predict glucose levels 30 minutes in advance to help prevent highs and lows.

Control-IQ technology automatically adjusts insulin dosing based on continuous glucose monitoring (CGM) readings.

The Freedom to Bolus

The t:connect mobile app frees you to bolus from your compatible smartphone without touching your pump.*

Automatic Correction Boluses

It can also deliver automatic correction boluses (up to one an hour) to help prevent hyperglycemia.^†

Activity Settings

Includes optional settings for Sleep Activity or Exercise Activity that adjust the range of treatment values.

Zero Fingersticks

For calibration or mealtime dosing, when the t:slim X2 insulin pump is integrated with Dexcom G6 CGM.^‡

Find out how easy control can be

Fill out the form below and start discovering the benefits of the t:slim X2 insulin pump with Control‑IQ technology. Our team members are ready to assist you!

All fields are required. By submitting this form, you grant Tandem Diabetes Care, Inc. permission to add your contact information to our database to send you information and communications related to our products. We respect and uphold the confidentiality of your personal information, and will not share your information with any third-parties, except as noted in our privacy policy.

More Time in Range^§

Average additional time in range per day for clinical study participants who used Control-IQ technology on the t:slim X2 insulin pump.¹

Said it’s Easy to Use

Percent of clinical study participants who used Control-IQ technology on the t:slim X2 insulin pump and said it was easy to use.²

Don’t take our word for it!

Hear from people of all ages who have experienced the life‑changing benefits of Control‑IQ technology.

More Testimonials

How it Works

Control‑IQ technology is designed to help increase time in range^{^} using Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly. Icons on the pump screen indicate when insulin dosing is increasing, decreasing, or being stopped by the system.

Our insulin pumps are positively impacting people’s lives

It means a lot to my family to see me healthy, playing professional football, and living my dream. The technology the t:slim X2 pump has is incredible. It would feel like the dark ages if I gave myself shots.

Mark Andrews

Tight End, Baltimore Ravens ◇

I have different Personal Profiles in my pump that I use depending on the amount of training I have had in the few days prior. My t:slim X2 pump and Dexcom are crucial during this training period.

Lauren Salko

Professional Freestyle Skier ◇

Tandem Diabetes Care has made a difference in not just my life, but in my family’s life. My mom used to come to school to give me insulin. Now that I have a t:slim X2 pump, I can just do it myself.

Jillian

Diagnosed 2011

Typically my blood sugar drops at night while I’m asleep. The t:slim X2 insulin pump with its predictive technology was able to prevent lows almost every single time. It's a game changer!

Ben Tzeel

MPH, RD, CSCS ◇

The t:slim X2 insulin pump from Tandem fits my lifestyle. It's easier for me when I’m on the go and doing activities that require more focus. An insulin pump is also less painful than taking shots.

Madeleine

Diagnosed 2013

Responsible Use of Control‑IQ Technology

Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, users are still responsible for actively managing their diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires that users accurately input information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless all system components, including CGM, infusion sets and pump cartridges, are used as instructed. Importantly, the system cannot adjust insulin dosing if the pump is not receiving CGM readings. Because there are situations and emergencies that the system may not be capable of identifying or addressing, users should always pay attention to their symptoms and treat accordingly.

* Bolus delivery from the t:connect mobile app requires a compatible smartphone model and operating system, an app update, a remote software update on the customer’s t:slim X2 insulin pump and additional training. Only available to customers who reside in the United States.

† If glucose values are predicted to be above 180 mg/dL, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value. An Automatic Correction Bolus will not occur within 60 minutes of a bolus that has been delivered or cancelled.

‡ Dexcom CGM sold separately. Zero fingersticks required when using the t:slim X2 pump with Dexcom G6 CGM integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

§ As measured by CGM.

^ Time in range is defined as 70-180 mg/dL.

◇ Tandem Diabetes Care has a compensation agreement with Mark Andrews, Lauren Salko, and Ben Tzeel.

References

1. Brown SA, Kovatchev BP, Raghinaru D, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Eng J Med. 2019;381(18):1701-1717. doi: 10.1056/NEJMoa1907863.

2. Brown SA. Clinical acceptance of the artificial pancreas: Glycemia outcomes from a 6-month multicenter RCT. Poster presented at 79th Scientific Sessions of the American Diabetes Association; June 7-11, 2019; San Francisco, CA.

Important Safety Information

RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with U-100 insulin only. t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

Warning: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

t:connect mobile app: The feature set available within the t:connect mobile app is dependent on the pump software version and the compatible smartphone’s model and operating system (OS).

The Display and Data Upload feature set provides a secondary display of pump and continuous glucose monitoring (CGM) information, including display of your pump alerts and alarms, and enables wireless uploading of pump and CGM data to the Tandem cloud through an internet or wireless data connection. Standard carrier data rates may apply.
The Bolus Delivery plus Display and Data Upload feature set additionally allows users to request, stop, and cancel a bolus on the pump from the t:connect mobile app. At least one smartphone security setting must be enabled to utilize the Bolus Delivery feature of the t:connect mobile app.
WARNING: Always rely on your pump to make therapy decisions when using a smartphone that is incompatible with the Bolus Delivery feature.
PRECAUTIONS: Always rely on your pump to make therapy decisions if using a smartphone that is incompatible, the smartphone is lost or damaged, or the smartphone loses Bluetooth® connectivity with your pump. Important pump alerts and alarms are only received as app notifications when enabled and the app is either active or running in the background.

Select Country

See how easy control can be

The Freedom to Bolus

Automatic Correction Boluses

Activity Settings

Zero Fingersticks

Find out how easy control can be

More Time in Range^§

Said it’s Easy to Use

Don’t take our word for it!

How it Works

Our insulin pumps are positively impacting people’s lives

About Tandem

Disclosures

Newsletter Signup

t:slim X2 Insulin Pump

Software & Apps

Diabetes Education

Pump Training